Yoonho Chung1, Jean Addington2, Carrie E Bearden3, Kristin Cadenhead4, Barbara Cornblatt5, Daniel H Mathalon6, Thomas McGlashan7, Diana Perkins8,9, Larry J Seidman10,11, Ming Tsuang4, Elaine Walker12, Scott W Woods7, Sarah McEwen3, Theo G M van Erp13, Tyrone D Cannon1,7. 1. Department of Psychology, Yale University, New Haven, Connecticut. 2. Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. 3. Semel Institute for Neuroscience and Human Behavior, Department of Psychology, University of California, Los Angeles. 4. Department of Psychiatry, University of California, San Diego, La Jolla. 5. Department of Psychiatry, Zucker Hillside Hospital, Queens, New York. 6. Department of Psychiatry, University of California, San Francisco. 7. Department of Psychiatry, Yale University, New Haven, Connecticut. 8. Department of Psychiatry, University of North Carolina, Chapel Hill. 9. Renaissance Computing Institute, University of North Carolina, Chapel Hill. 10. Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. 11. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston. 12. Department of Psychology, Emory University, Atlanta, Georgia. 13. Department of Psychiatry and Human Behavior, University of California, Irvine.
Abstract
Importance: Altered neurodevelopmental trajectories are thought to reflect heterogeneity in the pathophysiologic characteristics of schizophrenia, but whether neural indicators of these trajectories are associated with future psychosis is unclear. Objective: To investigate distinct neuroanatomical markers that can differentiate aberrant neurodevelopmental trajectories among clinically high-risk (CHR) individuals. Design, Setting, and Participants: In this prospective longitudinal multicenter study, a neuroanatomical-based age prediction model was developed using a supervised machine learning technique with T1-weighted magnetic resonance imaging scans of 953 healthy controls 3 to 21 years of age from the Pediatric Imaging, Neurocognition, and Genetics (PING) study and then applied to scans of 275 CHR individuals (including 39 who developed psychosis) and 109 healthy controls 12 to 21 years of age from the North American Prodrome Longitudinal Study 2 (NAPLS 2) for external validation and clinical application. Scans from NAPLS 2 were collected from January 15, 2010, to April 30, 2012. Main Outcomes and Measures: Discrepancy between neuroanatomical-based predicted age (hereafter referred to as brain age) and chronological age. Results: The PING-derived model (460 females and 493 males; age range, 3-21 years) accurately estimated the chronological ages of the 109 healthy controls in the NAPLS 2 (43 females and 66 males; age range, 12-21 years), providing evidence of independent external validation. The 275 CHR individuals in the NAPLS 2 (111 females and 164 males; age range, 12-21 years) showed a significantly greater mean (SD) gap between model-predicted age and chronological age (0.64 [2.16] years) compared with healthy controls (P = .008). This outcome was significantly moderated by chronological age, with brain age systematically overestimating the ages of CHR individuals who developed psychosis at ages 12 to 17 years but not the brain ages of those aged 18 to 21 years. Greater brain age deviation was associated with a higher risk for developing psychosis (F = 3.70; P = .01) and a pattern of stably poor functioning over time, but only among younger CHR adolescents. Previously reported evidence of accelerated reduction in cortical thickness among CHR individuals who developed psychosis was found to apply only to those who were 18 years of age or older. Conclusions and Relevance: These results are consistent with the view that neuroanatomical markers of schizophrenia may help to explain some of the heterogeneity of this disorder, particularly with respect to early vs later age of onset of psychosis, with younger and older individuals having differing intercepts and trajectories in structural brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are likely to be useful in estimating onset of psychosis, especially (or only) among CHR individuals with an earlier age of onset of prodromal symptoms.
Importance: Altered neurodevelopmental trajectories are thought to reflect heterogeneity in the pathophysiologic characteristics of schizophrenia, but whether neural indicators of these trajectories are associated with future psychosis is unclear. Objective: To investigate distinct neuroanatomical markers that can differentiate aberrant neurodevelopmental trajectories among clinically high-risk (CHR) individuals. Design, Setting, and Participants: In this prospective longitudinal multicenter study, a neuroanatomical-based age prediction model was developed using a supervised machine learning technique with T1-weighted magnetic resonance imaging scans of 953 healthy controls 3 to 21 years of age from the Pediatric Imaging, Neurocognition, and Genetics (PING) study and then applied to scans of 275 CHR individuals (including 39 who developed psychosis) and 109 healthy controls 12 to 21 years of age from the North American Prodrome Longitudinal Study 2 (NAPLS 2) for external validation and clinical application. Scans from NAPLS 2 were collected from January 15, 2010, to April 30, 2012. Main Outcomes and Measures: Discrepancy between neuroanatomical-based predicted age (hereafter referred to as brain age) and chronological age. Results: The PING-derived model (460 females and 493 males; age range, 3-21 years) accurately estimated the chronological ages of the 109 healthy controls in the NAPLS 2 (43 females and 66 males; age range, 12-21 years), providing evidence of independent external validation. The 275 CHR individuals in the NAPLS 2 (111 females and 164 males; age range, 12-21 years) showed a significantly greater mean (SD) gap between model-predicted age and chronological age (0.64 [2.16] years) compared with healthy controls (P = .008). This outcome was significantly moderated by chronological age, with brain age systematically overestimating the ages of CHR individuals who developed psychosis at ages 12 to 17 years but not the brain ages of those aged 18 to 21 years. Greater brain age deviation was associated with a higher risk for developing psychosis (F = 3.70; P = .01) and a pattern of stably poor functioning over time, but only among younger CHR adolescents. Previously reported evidence of accelerated reduction in cortical thickness among CHR individuals who developed psychosis was found to apply only to those who were 18 years of age or older. Conclusions and Relevance: These results are consistent with the view that neuroanatomical markers of schizophrenia may help to explain some of the heterogeneity of this disorder, particularly with respect to early vs later age of onset of psychosis, with younger and older individuals having differing intercepts and trajectories in structural brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are likely to be useful in estimating onset of psychosis, especially (or only) among CHR individuals with an earlier age of onset of prodromal symptoms.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: Christian K Tamnes; Ylva Ostby; Anders M Fjell; Lars T Westlye; Paulina Due-Tønnessen; Kristine B Walhovd Journal: Cereb Cortex Date: 2009-06-11 Impact factor: 5.357
Authors: Nikolaos Koutsouleris; Christos Davatzikos; Stefan Borgwardt; Christian Gaser; Ronald Bottlender; Thomas Frodl; Peter Falkai; Anita Riecher-Rössler; Hans-Jürgen Möller; Maximilian Reiser; Christos Pantelis; Eva Meisenzahl Journal: Schizophr Bull Date: 2013-10-13 Impact factor: 9.306
Authors: Yoonho Chung; Aron Jacobson; George He; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen; Tyrone D Cannon Journal: Mol Neuropsychiatry Date: 2015-05-01
Authors: Yoonho Chung; Kristen M Haut; George He; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Tyrone D Cannon Journal: Schizophr Res Date: 2017-02-27 Impact factor: 4.939
Authors: Timothy T Brown; Joshua M Kuperman; Yoonho Chung; Matthew Erhart; Connor McCabe; Donald J Hagler; Vijay K Venkatraman; Natacha Akshoomoff; David G Amaral; Cinnamon S Bloss; B J Casey; Linda Chang; Thomas M Ernst; Jean A Frazier; Jeffrey R Gruen; Walter E Kaufmann; Tal Kenet; David N Kennedy; Sarah S Murray; Elizabeth R Sowell; Terry L Jernigan; Anders M Dale Journal: Curr Biol Date: 2012-08-16 Impact factor: 10.834
Authors: Katrina Aberizk; Meghan A Collins; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Tyrone D Cannon; Elaine F Walker Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-04-28
Authors: Sheng He; Diana Pereira; Juan David Perez; Randy L Gollub; Shawn N Murphy; Sanjay Prabhu; Rudolph Pienaar; Richard L Robertson; P Ellen Grant; Yangming Ou Journal: Med Image Anal Date: 2021-04-30 Impact factor: 13.828
Authors: Maria A Di Biase; Suheyla Cetin-Karayumak; Amanda E Lyall; Andrew Zalesky; Kang Ik Kevin Cho; Fan Zhang; Marek Kubicki; Yogesh Rathi; Monica G Lyons; Sylvain Bouix; Tashrif Billah; Alan Anticevic; Charlie Schleifer; Brendan D Adkinson; Jie Lisa Ji; Zailyn Tamayo; Jean Addington; Carrie E Bearden; Barbara A Cornblatt; Matcheri S Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Kristen S Cadenhead; Ming T Tsuang; Scott W Woods; William S Stone; Martha E Shenton; Tyrone D Cannon; Ofer Pasternak Journal: Mol Psychiatry Date: 2021-05-24 Impact factor: 13.437
Authors: Du Lei; Walter H L Pinaya; Jonathan Young; Therese van Amelsvoort; Machteld Marcelis; Gary Donohoe; David O Mothersill; Aiden Corvin; Sandra Vieira; Xiaoqi Huang; Su Lui; Cristina Scarpazza; Celso Arango; Ed Bullmore; Qiyong Gong; Philip McGuire; Andrea Mechelli Journal: Hum Brain Mapp Date: 2019-11-18 Impact factor: 5.399
Authors: Yoonho Chung; Dana Allswede; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Sarah McEwen; Theo G M van Erp; Tyrone D Cannon Journal: Neuroimage Clin Date: 2019-05-23 Impact factor: 4.881